Apollo Hospitals Gains 2.16%: 3 Key Factors Driving the Weekly Rally

24 August 2026: Steady Start Amid Market Weakness

Apollo Hospitals began the week on a positive note, closing at Rs.8,700.00, up 0.47% despite the Sensex declining 0.12% to 36,770.21. The stock’s outperformance on a broadly negative market day indicated underlying strength and investor interest in the healthcare sector. Trading volume was robust at 24,334 shares, signalling active participation.

25 August 2026: Strong Buy Upgrade Spurs 2.05% Rally

The highlight of the week came on 25 August when MarketsMOJO upgraded Apollo Hospitals from a 'Buy' to a 'Strong Buy' rating. This upgrade was driven by robust financials, including a return on capital employed (ROCE) of 17.13%, strong net sales growth of 16.82% annualised, and an impressive operating profit growth of 23.85%. The company’s market capitalisation stood at ₹1,27,652 crores, cementing its leadership in the hospital sector.

Following the upgrade, the stock surged 2.05% to close at Rs.8,878.00, near its 52-week high of Rs.9,326.80. This price action reflected strong buying interest and positive sentiment, supported by improved technical momentum and attractive valuation metrics such as an EV/CE ratio of 8.5 and a PEG ratio of 1.8. The Sensex also gained 0.36% that day, but Apollo’s outperformance was notable.

26 August 2026: Technical Momentum Shift Amid Slight Price Correction

On 26 August, Apollo Hospitals experienced a minor price correction, closing at Rs.8,790.00, down 0.99%. This dip coincided with a mixed technical picture. While the weekly MACD and KST indicators showed mild bearishness, monthly indicators remained bullish, signalling a strengthening long-term uptrend despite short-term consolidation.

The stock traded within a range of Rs.8,640.00 to Rs.8,878.00, maintaining levels well above key moving averages including the 5-day, 50-day, 100-day, and 200-day averages. The Relative Strength Index (RSI) remained neutral, indicating no immediate overbought conditions. The Sensex was nearly flat, down 0.03% at 36,890.31.

This technical momentum shift suggested a cautious near-term outlook but reinforced confidence in the stock’s medium- to long-term trajectory, supported by strong fundamentals and sector leadership.

27 August 2026: Bullish Derivatives Activity Signals Growing Market Confidence

Apollo Hospitals saw a significant 13.75% surge in open interest in its derivatives segment, rising from 28,865 to 32,835 contracts. This increase accompanied steady price performance near the 52-week high, closing at Rs.8,805.50, up 0.18%. The futures segment alone accounted for a notional value of approximately ₹10,411.79 lakhs, while options stood at ₹14,459.42 crores, reflecting substantial market participation.

The rise in open interest alongside steady volume indicated fresh capital inflows and bullish positioning by traders. Despite a 54.48% drop in delivery volumes to 78,820 shares, the stock’s liquidity remained adequate to support active derivatives trading without significant price impact.

Relative to the hospital sector’s modest 0.18% gain and the Sensex’s 0.24% decline, Apollo’s outperformance underscored its resilience and leadership. The derivatives activity suggested anticipation of further gains, supported by the company’s upgraded Mojo Grade and strong fundamentals.

28 August 2026: Week Closes on a Positive Note

Closing the week on 28 August, Apollo Hospitals gained 0.46% to Rs.8,845.70, supported by a volume of 14,322 shares. The Sensex also recovered slightly, rising 0.26% to 36,794.04. The stock’s weekly performance of +2.16% contrasted with the Sensex’s marginal decline of 0.05%, highlighting Apollo’s relative strength and investor preference.

The stock remains well-positioned above key moving averages, with technical indicators suggesting sustained bullish momentum over the medium term. The combination of strong fundamentals, positive technical signals, and active derivatives interest provides a comprehensive picture of confidence in the company’s prospects.

Key Takeaways

Positive Signals: Apollo Hospitals demonstrated strong operational and financial performance, reflected in its upgrade to a 'Strong Buy' rating. The company’s ROCE of 17.13%, consistent net profit growth, and attractive valuation metrics underpin its sector leadership. Technical momentum shifted positively with bullish daily moving averages and monthly MACD, supporting further upside potential.

Cautionary Notes: Short-term technical indicators such as weekly MACD and KST showed mild bearishness, suggesting possible consolidation or minor pullbacks. The sharp decline in delivery volumes alongside rising derivatives open interest indicates a shift in trading preference, which may introduce volatility. Investors should monitor key moving averages, especially the 20-day average, for confirmation of sustained momentum.

Conclusion

Apollo Hospitals Enterprise Ltd. delivered a commendable weekly performance, gaining 2.16% and outperforming the Sensex by over 2 percentage points. The week was marked by a significant upgrade to a 'Strong Buy' rating, reflecting robust fundamentals and improved technical momentum. The surge in derivatives open interest further signals growing market confidence in the stock’s prospects.

While short-term technical signals advise caution, the overall outlook remains positive, supported by strong financials, sector leadership, and favourable market positioning. Apollo Hospitals continues to be a key player in the hospital sector, with sustained earnings growth and attractive valuation metrics that justify investor attention.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today